Rick E Winningham
2010 - Innoviva
In 2010, Rick E Winningham earned a total compensation of $1.9M as Chief Executive Officer at Innoviva, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $26,163 |
|---|---|
| Non-Equity Incentive Plan | $570,824 |
| Salary | $792,811 |
| Stock Awards | $556,600 |
| Total | $1,946,398 |
Winningham received $792.8K in salary, accounting for 41% of the total pay in 2010.
Winningham also received $26.2K in bonus, $570.8K in non-equity incentive plan and $556.6K in stock awards.
Rankings
In 2010, Rick E Winningham's compensation ranked 3,147th out of 10,439 executives tracked by ExecPay. In other words, Winningham earned more than 69.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,147 out of 10,439 | 70th |
Division Manufacturing | 1,097 out of 3,838 | 71st |
Major group Chemicals And Allied Products | 210 out of 921 | 77th |
Industry group Drugs | 111 out of 680 | 84th |
Industry Pharmaceutical Preparations | 86 out of 481 | 82nd |
Source: SEC filing on March 12, 2013.
Winningham's colleagues
We found four more compensation records of executives who worked with Rick E Winningham at Innoviva in 2010.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019